Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Cardiology and Therapy|June 14, 2015
Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood PressureManuel GorostidiAdvances in Therapy|April 5, 2013
Combination therapy in hypertensionManuel Gorostidi, Alejandro de la SierraExpert Review of Clinical Pharmacology|August 10, 2018
Combination therapies for hypertension - why we need to look beyond RAS blockersManuel Gorostidi, Alejandro de la SierraCurrent Opinion in Nephrology and Hypertension|September 16, 2015
Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements?Gema Ruiz-Hurtado, Manuel Gorostidi, Bernard Waeber, et al.Kidney International. Supplement|December 13, 2005
Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosisRafael Marín, Manuel Gorostidi, Francisco Fernández-Vega, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 17, 2014
Prevalence of white-coat and masked hypertension in national and international registriesManuel Gorostidi, Ernest Vinyoles, José R Banegas, et al.Revista Espanola De Cardiologia (English Ed.)|December 10, 2014
Prevalence of Atherogenic Dyslipidemia in Spanish Hypertensive Patients and Its Relationship With Blood Pressure Control and Silent Organ DamageAlejandro de la Sierra, Manuel Gorostidi, Pedro Aranda, et al.Cardiology and Therapy|October 11, 2025
Impact of Office and Ambulatory Blood Pressure on Mortality in Patients with Coronary Heart DiseaseAlejandro de la Sierra, Ernest Vinyoles, Manuel Gorostidi, et al.Journal of Hypertension|February 7, 2012
Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event studyAlejandro de la Sierra, José R Banegas, Julián Segura, et al.Journal of Hypertension|May 16, 2009
Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trialRoland E Schmieder, Thomas Philipp, Javier Guerediaga, et al.Pageof 8